SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences registers rise of 16% in Q3

01 Feb 2012 Evaluate

Suven Life Sciences has registered a rise of 16.21% in net profit to Rs 1.29 crore for the third quarter ended December 31, 2011. The company had posted a net profit of Rs 1.11 crore in the corresponding period of previous fiscal.

The company’s net income from sales and services rose to Rs 48.72 crore for the third quarter, compared to Rs 32.06 crore in the same period previous fiscal, up by 51.97%.

In addition, the company said that with effect from December 31, 2011, Suven Nishtaa Pharma has become a wholly-owned subsidiary of the company. Further, the company said its board at its meeting held on January 31, 2012 has given its consent for amalgamation of Suven Nishtaa Pharma with Suven Life Sciences subject to the approval of the scheme by the High Court of Andhra Pradesh.

Suven Life Sciences Share Price

224.15 3.45 (1.56%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×